Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized, Double-blind Placebo-controlled Clinical Study to Assess Safety, Tolerance, Pharmacokinetics, Pharmacodynamic of multiple-dose Kukoamine B Mesilate in Sepsis Patients

Trial Profile

Randomized, Double-blind Placebo-controlled Clinical Study to Assess Safety, Tolerance, Pharmacokinetics, Pharmacodynamic of multiple-dose Kukoamine B Mesilate in Sepsis Patients

Recruiting
Phase of Trial: Phase I

Latest Information Update: 04 May 2018

At a glance

  • Drugs Kukoamine B (Primary)
  • Indications Sepsis
  • Focus Adverse reactions
  • Sponsors Tianjin Chase Sun Pharmaceutical
  • Most Recent Events

    • 28 Apr 2018 Planned End Date changed from 17 Jul 2018 to 31 Dec 2018.
    • 28 Apr 2018 Planned primary completion date changed from 5 Apr 2018 to 31 Dec 2018.
    • 03 Aug 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top